Loading clinical trials...
Loading clinical trials...
Transplantation of Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation or Cyclophosphamide/Fludarabine/Thiotepa/Total Body Irradiation Myeloablative Preparative Regimen
Conditions
Interventions
Cyclophosphamide
Cyclosporine
+7 more
Locations
3
United States
University of Colorado Hospital
Aurora, Colorado, United States
VA Puget Sound Health Care System
Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
November 18, 2005
Primary Completion Date
December 22, 2023
Completion Date
December 19, 2024
Last Updated
March 7, 2025
NCT06735690
NCT05564390
NCT03050268
NCT06074666
NCT07320235
NCT06782542
Lead Sponsor
Fred Hutchinson Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions